SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,814,259 | -25.4% | 1,675,579 | 0.0% | 1.78% | +30.1% |
Q2 2023 | $7,791,442 | +0.6% | 1,675,579 | 0.0% | 1.37% | -14.5% |
Q1 2023 | $7,741,175 | -42.8% | 1,675,579 | 0.0% | 1.60% | -45.1% |
Q4 2022 | $13,538,678 | +45.6% | 1,675,579 | 0.0% | 2.91% | +34.4% |
Q3 2022 | $9,299,000 | +6.5% | 1,675,579 | 0.0% | 2.17% | -6.8% |
Q2 2022 | $8,730,000 | -36.6% | 1,675,579 | 0.0% | 2.33% | -32.9% |
Q1 2022 | $13,773,000 | -44.8% | 1,675,579 | 0.0% | 3.47% | -28.3% |
Q4 2021 | $24,933,000 | -21.2% | 1,675,579 | 0.0% | 4.84% | -2.6% |
Q3 2021 | $31,652,000 | +1.6% | 1,675,579 | 0.0% | 4.97% | +29.2% |
Q2 2021 | $31,149,000 | -18.3% | 1,675,579 | 0.0% | 3.84% | -45.3% |
Q1 2021 | $38,136,000 | +4.8% | 1,675,579 | 0.0% | 7.03% | +92.3% |
Q4 2020 | $36,377,000 | +116.0% | 1,675,579 | 0.0% | 3.66% | -22.1% |
Q3 2020 | $16,840,000 | +29.5% | 1,675,579 | 0.0% | 4.70% | +12.3% |
Q2 2020 | $13,002,000 | +13.2% | 1,675,579 | +48.9% | 4.18% | -36.7% |
Q1 2020 | $11,481,000 | -7.3% | 1,125,579 | 0.0% | 6.61% | +11.4% |
Q4 2019 | $12,381,000 | +21.0% | 1,125,579 | 0.0% | 5.93% | -14.8% |
Q3 2019 | $10,232,000 | -20.1% | 1,125,579 | 0.0% | 6.96% | -17.7% |
Q2 2019 | $12,809,000 | -0.1% | 1,125,579 | 0.0% | 8.46% | -16.0% |
Q1 2019 | $12,820,000 | +26.3% | 1,125,579 | +0.0% | 10.08% | +3.4% |
Q4 2018 | $10,153,000 | – | 1,125,576 | – | 9.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |